Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Primary Immunodeficiencies (PID)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07660783
What this trial is testing

Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

Who this might be right for
Bone Marrow FailureHemoglobinopathiesPrimary Immune Deficiency (PID)+4 more
Fred Hutchinson Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT00814320
What this trial is testing

Gammagard Liquid and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 89
Large-scale testing (Phase 3)Study completedNCT00157079
What this trial is testing

Safety and Efficacy Study of a 10% Intravenous Immune Globulin Solution in Subjects With Primary Immunodeficiency Disorders

Who this might be right for
Primary Immunodeficiency Diseases (PID)Immune Thrombocytopenic Purpura (ITP)Kawasaki Syndrome
Baxalta now part of Shire 61
Large-scale testing (Phase 3)Study completedNCT01012323
What this trial is testing

NewGam, Human Immunoglobulin 10%, in Patients With Primary Immunodeficiency Diseases

Who this might be right for
Primary Immunodeficiency Diseases
Octapharma 51
Large-scale testing (Phase 3)Study completedNCT01581593
What this trial is testing

Efficacy and Safety Study of Kedrion IVIG 10% to Treat Subjects With Primary Immunodeficiency (PID)

Who this might be right for
Primary ImmunodeficiencyAgammaglobulinemiaHypogammaglobulinemia+1 more
Kedrion S.p.A. 45
Testing effectiveness (Phase 2)Looking for participantsNCT01962415
What this trial is testing

Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+4 more
Paul Szabolcs 100
Not applicableLooking for participantsNCT06565078
What this trial is testing

A Database Survey to Evaluate the Safety of Immune Globulin Subcutaneous (Human), 20% Solution in Participants With Primary Immunodeficiency

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Takeda 100
Large-scale testing (Phase 3)Study completedNCT01175213
What this trial is testing

Tolerability and Safety of Immune Globulin Subcutaneous Solution (IGSC) and rHuPH20 in PID

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 66
Large-scale testing (Phase 3)Study completedNCT02327351
What this trial is testing

TCR Alpha/Beta Depletion for HSCT From Haploidentical and Unrelated Donors in the Treatment of PID

Who this might be right for
Primary Immune Deficiency DisorderHematopoietic Stem Cell Transplantation
Federal Research Institute of Pediatric Hematology, Oncology and Immunology 98
Large-scale testing (Phase 3)Looking for participantsNCT06954441
What this trial is testing

V-IMMUNE: A Novel Immunoglobulin Therapy for Immunodeficiency

Who this might be right for
ImmunodeficienciesPrimary Immunodeficiencies (PID)Agammaglobulinemia
On Pharma Importadora, Exportadora e Distribuidora de Medicamentos LTDA. 50
Large-scale testing (Phase 3)Study completedNCT01814800
What this trial is testing

Pharmacokinetics, Efficacy, and Safety Study of RI-002 (IGIV) in Subjects With Primary Immunodeficiency Diseases (PIDD)

Who this might be right for
Primary Immune Deficiency Disorder
ADMA Biologics, Inc. 59
Large-scale testing (Phase 3)Study completedNCT00719680
What this trial is testing

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immune Deficiency
CSL Behring 21
Large-scale testing (Phase 3)Looking for participantsNCT07346859
What this trial is testing

Study of BP-SCIG 20% in Patients With Primary Immunodeficiency (PID)

Who this might be right for
Primary Immunodeficiency Diseases
Biopharma Plasma LLC 56
Large-scale testing (Phase 3)Study completedNCT03961009
What this trial is testing

Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in PID Patients

Who this might be right for
Primary Immunodeficiency Disease
Kedrion S.p.A. 47
Large-scale testing (Phase 3)Study completedNCT01313507
What this trial is testing

High Infusion Rate Study of Immunoglobulin Intravenous (Human) 10% (NewGam)

Who this might be right for
Primary Immunodeficiency Disease
Octapharma 21
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554914
What this trial is testing

Evaluate Tabelecleucel in Participants With Epstein Barr Virus (EBV) Associated Diseases

Who this might be right for
Epstein-Barr Virus (EBV)-Associated DiseasesEBV+ Lymphoproliferative Disease With Primary Immunodeficiency (EBV+ PID LPD)EBV+ Lymphoproliferative Disease With Acquired (Non-congenital) Immunodeficiency (EBV+ AID LPD)+8 more
Pierre Fabre Medicament
Post-approval studies (Phase 4)Study completedNCT02180763
What this trial is testing

Gammanorm Quality of Life Study in Immunodeficient Patients Using Rapid Push or Pumps

Who this might be right for
Primary Immunodeficiency (PID)
Octapharma 31
Large-scale testing (Phase 3)Study completedNCT01199705
What this trial is testing

Study of Subcutaneous Immune Globulin in Patients Requiring IgG Replacement Therapy (Japan Study)

Who this might be right for
Primary Immune Deficiency
CSL Behring 25
Post-approval studies (Phase 4)Study completedNCT03116347
What this trial is testing

Post-Authorization Safety, Tolerability and Immunogenicity Evaluation of HyQvia in Pediatric PIDD Subjects

Who this might be right for
Primary Immunodeficiency Diseases (PID)
Baxalta now part of Shire 42
Not applicableLooking for participantsNCT01222741
What this trial is testing

Studies of Disorders With Increased Susceptibility to Fungal Infections

Who this might be right for
Fungal InfectionsPrimary Immune Deficiencies
National Institute of Allergy and Infectious Diseases (NIAID) 850
Next Page
190